NCT07062302

Brief Summary

The goal of this phase 2 clinical trial is to examine the effectiveness of photobiomodulation in patients with vocal fatigue. The main question it aims to answer is whether photobiomodulation is able to alleviate vocal fatigue in patients with diagnosed vocal fatigue. Participants will ask to receive photobiomodulation treatment for 12 sessions over a three week period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 9, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 12, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 12, 2024

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

June 24, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 14, 2025

Completed
Last Updated

July 14, 2025

Status Verified

July 1, 2025

Enrollment Period

2 months

First QC Date

June 24, 2025

Last Update Submit

July 2, 2025

Conditions

Keywords

vocal fatiguevoice disordersphotobiomodulationlow-level light therapy

Outcome Measures

Primary Outcomes (1)

  • Vocal Fatigue Measure: Vocal Fatigue Index (VFI-HK)

    The VFI(HK) contains 19 items in three domains (i) tiredness of voice and avoidance of voice use (ii) physical discomfort and (iii) improvement of symptoms after rest. All items are rated on a scale from zero (0, meaning "never") to four (4, meaning "always"). The score ranges from 0 to 76, with higher score indicating worst outcome.

    This will be measured at baseline (pre-treatment) and within 2-weeks after the completion of treatment (post-treatment).

Secondary Outcomes (3)

  • Vocal function measure: Voice Handicap Index - 30

    This will be measured at baseline (pre-treatment) and within 2-weeks after the completion of treatment (post-treatment).

  • Vocal Function Measure: Aerodynamic assessment

    This will be measured at baseline (pre-treatment) and within 2-weeks after the completion of treatment (post-treatment).

  • Vocal Function Measures: Acoustic voice analysis

    This will be measured at baseline (pre-treatment) and within 2-weeks after the completion of treatment (post-treatment).

Study Arms (1)

Photobiomodulation arm

EXPERIMENTAL
Device: photobiomodulation

Interventions

The output of the photobiomodulation device is listed as below: * Irradiation size: 15 cm × 10 cm * Dual-wavelength: 660 nm + 850 nm * Optical power density: 10 - 15 mW/cm2 * Dose density: 6J/cm2

Also known as: low level light therapy
Photobiomodulation arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged over 18 years old
  • Meeting the diagnosis of vocal fatigue as per the VFI-HK
  • Able to make informed consent
  • Have not received any voice therapy before

You may not qualify if:

  • History of photoallergy
  • Significant medical or chronic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Chinese University of Hong Kong

Shatin, N.T., Hong Kong

Location

Related Publications (2)

  • Moreno M, Calvache C, Cantor-Cutiva LC. Systematic Review of Literature on Prevalence of Vocal Fatigue Among Teachers. J Voice. 2025 Jan;39(1):105-112. doi: 10.1016/j.jvoice.2022.07.029. Epub 2022 Sep 20.

    PMID: 36137877BACKGROUND
  • Welham NV, Maclagan MA. Vocal fatigue: current knowledge and future directions. J Voice. 2003 Mar;17(1):21-30. doi: 10.1016/s0892-1997(03)00033-x.

    PMID: 12705816BACKGROUND

MeSH Terms

Conditions

Voice Disorders

Interventions

Low-Level Light Therapy

Condition Hierarchy (Ancestors)

Laryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Photobiomodulation
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 24, 2025

First Posted

July 14, 2025

Study Start

March 9, 2024

Primary Completion

May 12, 2024

Study Completion

June 12, 2024

Last Updated

July 14, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

The data that support the findings of this study are available from the investigator, TL, upon reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
June 2025

Locations